Diabetes treatment pump trial begins in Canada
A Phase I trial evaluating Adocia’s BioChaperone® Lispro Pramlintide formulation for insulin pump delivery in type 1 diabetics has begun.
List view / Grid view
A Phase I trial evaluating Adocia’s BioChaperone® Lispro Pramlintide formulation for insulin pump delivery in type 1 diabetics has begun.
Exceptions to high quality research should not be made simply because of the COVID-19 pandemic, argue scientists in a new commentary.
Maintaining public confidence in the use of Big Data for health research is essential, according to international researchers.
Poor animal study design and reporting prevent the ethical review of proposed human drug trials, according to a team of international researchers...
The use of certain diabetes drugs, known as dipeptidyl peptidase-4 inhibitors, are associated with an increased risk of inflammatory bowel disease...
A study suggests long-term inhaled corticosteroids (ICS) in patients with COPD may increase the risk of bone fractures in both men and women...
Scientists have used artificial intelligence capable of recognising the signatures of dementia two years before its onset...